Growth momentum MVision AI recently expanded Workspace+ availability to New Zealand and launched Dose+, signaling active product expansion, geographic growth, and a broader addressable market in radiotherapy workflow optimization.

Strategic partnerships Ongoing collaborations with Philips Lighting, Meditest, CMS Alphatech, and alphaXRT indicate a strong partner-led distribution model to accelerate adoption across CT simulation, QA, and radiotherapy clinics in multiple regions.

Clinical automation focus Contouring automation and dose prediction tools address high-value workflow bottlenecks, offering potential upsell opportunities to clinics seeking efficiency gains, guideline-based accuracy, and standardized processes.

Customer success emphasis Recent addition of a dedicated Customer Success Manager suggests a focus on onboarding, retention, and expansion within existing accounts, creating opportunities for cross-sell and expansion of workspace modules.

Finance and scale signals Revenue is in the low-mid multi-million range with substantial growth potential from new deployments and product launches, supported by disclosed funding and a scalable SaaS-like platform.